If you are:
Not Recommended: NO FDA CATEGORY; NEONATAL COMPLICATIONS( RESP,GI,CNS)W/EXPOSURE IN 3RD TRIMESTER
Precaution: LOW AMNT EXCR W/SIMILAR DRUG CHLORPROMAZINE, RESULTING IN INFANT DROWSINESS
An adult over 60:
management or monitoring precaution: Neuro/Psych-Higher risk of tardive dyskinesia in the elderly. Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Increased risk of death in senile dementia. Cardiovascular-May cause orthostatic hypotension at higher doses. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Giving prochlorperazine Edisylate Vial to a child under 12:
management or monitoring precaution: Increased risk of extrapyramidal reactions. Avoid if suspected Reye syndrome.
Contraindication: Do not use in pediatrics under 2 years of age or if child is under 20 lbs per manufacturer.